「for」の検索結果
125件：91～95件目を表示
-
General Announcement: July 8, 2024 Senju Pharmaceutical Co., Ltd. Notice of Orphan Drug Designation for SJP-0008 as a Treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Head...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708.pdf -
NewMytear A | OTC Products, etc. | Products | SENJU Pharmaceutical
sium, and calcium was made closer to normal tears. This medicine contains calcium that is important for maintaining the function and transparency of the cornea. pH, osmotic pressure ratio, and viscosi...
http://www.senju.co.jp/english/products/myteara.html -
024 Senju Pharmaceutical Co., Ltd. Senju announces initiation of Phase III Clinical Trials in Japan for “SJP-0008” for the treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. ...
https://www.senju.co.jp/system/files/content_news/2024-05/ENG_20240509_0.pdf -
024 Senju Pharmaceutical Co., Ltd. Senju announces initiation of Phase III Clinical Trials in Japan for “SJP-0008” for the treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. ...
https://www.senju.co.jp/system/files/content_news/2024-05/ENG_20240509.pdf -
ral Announcement: Senju Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Senju has Applied for Manufacturing and Marketing Approval in Japan for the novel Dry Eye Disease treatment, SJP-0132 ...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117.pdf